Pfizer Inc. / Repevax Group / Meningococcal Serogroup / /
Country
United States / /
Event
FDA Phase / /
IndustryTerm
final drug product / final drug products / /
MedicalCondition
invasive meningococcal disease / strain / B disease / /
MedicalTreatment
active immunization / vaccination / /
Organization
Food and Drug Administration / Bacterial / Parasitic and Allergenic Products office of Vaccine Research / Freyja Lynn / BS Clinical Serology and Bioassay Reviewer Division of Bacterial / Division of Bacterial / Review Center for Biologics Evaluation and Research / DEPARTMENT OF HEALTH AND HUMAN SERVICES / Vaccine Research and Review Center for Biologics Evaluation and Research / /
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Silver Spring MD[removed]DATE: